Basant Maheshwari of Basant Maheshwari Wealth is of the view that pharma should be looked at but advises starting from the top notch companies, the bluechips.
According to Mitessh Thakkar of mitesshthakkar.com, one can sell Apollo Hospitals, Can Fin Home and ICICI Prudential Life and can buy Reliance Defence and Sun Pharma.
Pharma stocks like Divis Labs, Lupin, Aurobindo Pharma, Strides Shasun, Wockhrdt and Sun Pharma will get astrological support, says Satish Gupta of astrostocktips.
Prakash Gaba of prakashgaba.com is of the view that HDFC Bank can climb to Rs 1860 while Sun Pharma may test Rs 530.
Ashwani Gujral of ashwanigujral.com recommends selling Idea Cellular, Sun Pharma and Interglobe Aviation and advises buy Titan Company and UltraTech Cement.
The company is also entering into the third and the most important year of integration of Ranbaxy with the company.
Maybe that’s why amateur and professionals alike tend to lose their minds in bull markets, particularly when a hot initial public offering, or IPO, is offered to them by their broker.
The news highlights in the sector include first quarter results of Sun Pharma, Aurobindo Pharma, Cipla, Cadila Healthcare among others. The US pricing pressure looks more structural than a temporary event.
Shanghvi said the drug maker is giving top priority to bring back Halol unit under compliance
Sun Pharma is n focus after Taro, its US arm, reports a 30 percent decline in net sales. In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his readings and outlook on the same as well as on some other pharma stocks.
The Nifty Pharma index, itself, lost as much as 2.5 percent today, taking the total fall to 4.3 percent for three straight days.
According to Mitessh Thakkar of miteshhthakkar.com, one can sell Amara Raja Batteries, HDIL and Tata Motors DVR and buy Havells India.
For the week ahead, the index seems to be in a fix. If Index breaches the recent high of 10,115, then immediate resistance level stands at extrapolated levels 10,200 – 10,350 level in the near future.
According to Prakash Gaba of prakashgaba.com, crucial support for the Nifty is at 9920 and the resistance is at 10036-10069. On the other hand, Bank Nifty has support at 24650 and resistance at 25550.
L&T | ITC | ONGC | Idea | Claris Life | Duke Offshore | Dish TV | Sun Pharma and Nava Bharat Ventures are stocks, which are in news today.
CNBC-TV18 learns that Sun Pharma survives 'tax evasion' charge on intellectual property rights (IPR) transfer to foreign arm.
According to Prakash Gaba of prakashgaba.com, support for Nifty is placed at 9920 and resistance at 10036-69 while Bank Nifty has support at 24500 and resistance at 24775.
It is better to go via mutual fund route if one is not equipped to spend enough time in the market and understand the various nuances of investing.
US FDA also approved ANDA for Paroxetine Hydrochloride that filed by Sun Pharma.
Net Sales are expected to decrease by 2.39 percent Q-o-Q (down 16.79 percent Y-o-Y) to Rs 6662 crore, according to KR Choksey. Sun Pharma to report net profit at 1713.2 crore down 24.69% year-on-year.
According to Prakash Gaba of prakashgaba.com, crucial support for the Nifty is at 9675 and the resistance is at 9816. He has four bullish calls including Bosch, Eicher Motors, L&T and Sun Pharma.
"The agreement was entered into by Sun Pharma's wholly- owned subsidiary and Samsung BioLogics...Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis," the company said in a BSE filing.
Sun Pharma, India's largest drug maker on Tuesday, said it has entered into a strategic agreement with Samsung BioLogics to manufacture the former's psoriasis drug Tildrakizumab.